tiprankstipranks
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market
Holding CGON?
Track your performance easily

CG Oncology, Inc. (CGON) Financial Statements

112 Followers

CG Oncology, Inc. Financial Overview

CG Oncology, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.276; its P/E ratio is -26.40; CG Oncology, Inc. is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24
Income Statement-
Total Revenue$ 43.00K$ 111.00K$ 529.00K
Gross Profit$ 43.00K$ 111.00K$ 529.00K
EBIT$ -20.41M$ -18.90M$ -16.93M
EBITDA$ -20.38M$ -18.89M$ -16.93M
Net Income Common Stockholders$ -20.41M$ -18.90M$ -16.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 540.71M$ 552.88M$ 566.51M
Total Assets$ 552.47M$ 564.33M$ 579.11M
Total Debt$ 296.00K$ 355.00K$ 404.00K
Net Debt$ -540.41M$ -552.52M$ -566.10M
Total Liabilities$ 15.70M$ 11.97M$ 10.17M
Stockholders Equity$ 536.77M$ 552.36M$ 568.94M
Cash Flow-
Free Cash Flow$ -16.00M$ -16.11M$ -26.01M
Operating Cash Flow$ -16.00M$ -16.10M$ -26.00M
Investing Cash Flow$ 32.01M$ -36.23M$ -307.44M
Financing Cash Flow$ 2.17M$ 40.00K$ 402.66M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History

CG Oncology, Inc. Debt to Assets

CG Oncology, Inc. Cash Flow

CG Oncology, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis